S100B and myeloid sarcoma: Elevated levels of S100B were detected in the cerebrospinal fluid (CSF) [6,7] and sera [7] of MS patients in the acute phase, being reduced in the stationary phase of the disease, and an increased expression of S100B has been detected in both active demyelinating and chronic active MS plaques [8].